Aptinyx Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Chicago, IL USA
Total Funding:$237.4M
Industry:Biotech
Founded:2015
Lead Investor(s):Bain Capital Life Sciences

Industry Ranking

Estimated Revenue & Financials

  • Aptinyx's estimated annual revenue is currently $6.7M per year.
  • Aptinyx received $70.0M in venture funding in December 2017.
  • Aptinyx's estimated revenue per employee is $156,279
  • Aptinyx's total funding is $237.4M.

Employee Data

  • Aptinyx has 43 Employees.
  • Aptinyx grew their employee count by -23% last year.
  • Aptinyx currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Chromatin
$6.8M44N/AN/AN/A
Daigger
$4M26N/AN/AN/A
Project Farma
$16.1M10446%N/AN/A
Aptinyx
$6.7M43-23%N/AN/A
Heidolph North ...
$10.1M6516%N/AN/A
Orochem Technol...
$4.2M27N/AN/AN/A
Horizon Therape...
$207.9M13418%N/AN/A
Tempus
$138M89044%N/AN/A
Project Farma
$13.3M8623%N/AN/A
AveXis
$211.3M1363147%N/AN/A
Missing a competitor? Contribute!?
Submit

Welcome to our company page and thank you for your interest in Aptinyx Inc. Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. At Aptinyx, we remain committed and responsive to our employees. We offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. If you are interested in learning more, please visit our website at www.aptinyx.com.

keywords:N/A

43

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

-23%

Employee Growth %

$237.4M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Sarah TorriExecutive Director
Nayereh Ghoreishi-HaackSenior Research Manager
Tony SmolcichSenior Director Information TechnologyEmail Available
Katie HardekDirector, Human Resources
Amber JohnsonAssociate Director of FinanceEmail Available
Nick SmithSr. Director Of Corporate Development & Investor RelationsEmail Available
Torsten MeldgaardChief Medical Officer
Kevin NewkirkAssociate Director, Program Management
Dan WatsonSr. Clinical Operations Study ManagerEmail Available
Andy KiddChief Operating Officer

Aptinyx News

09/03/2019 - Aptinyx Reports Second Quarter 2019 Financial Results and ...

EVANSTON, Ill., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing ...

09/08/2019 - Aptinyx Inc.'s (APTX) CEO Norbert Riedel on Q2 2019 Results - Earnings Call Transcript

Aptinyx Inc. (NASDAQ:APTX) Q2 2019 Results Earnings Conference Call August 12, 2019 8:00 AM ET. Company Participants. Nick Smith ...

09/03/2019 - Form 8-K Aptinyx Inc. For: Aug 12

On August 12, 2019, Aptinyx Inc., issued a press release announcing its financial results for the quarter ended June 30, 2019. A copy of the ...

Aptinyx Funding

DateAmountRoundLead InvestorsReference
2016-05-10$65.0MANew Leaf Venture PartnersArticle
2017-12-19$70.0MBBain Capital Life SciencesArticle

Aptinyx Executive Hires

DateNameTitleReference
2017-12-08Andy KiddChief commercial officerArticle
2018-02-14Ashish KhannaChief Financial Officer and Chief Business OfficerArticle
2018-05-04David HouckChief Development OfficerArticle